Tirzepatide Units to Milligrams: A Converter Explainer

Trust signals

> Reviewed by FormBlends Medical Team · Last updated May 2026 · 10 sources cited · Author: FormBlends Editorial

Key Takeaways

• An insulin syringe measures volume in "units," where 100 units equals 1 mL. Tirzepatide is dosed by mass in milligrams.
• Converting units to milligrams requires the concentration of the specific vial, which varies by 503A compounding pharmacy.
• The formula is straightforward: volume in mL equals dose in mg divided by concentration in mg/mL, and units equals volume in mL times 100.
• Common compounded tirzepatide concentrations include 10, 20, 30, and 40 mg/mL. The vial label states the concentration.
• Unit/milligram confusion is a documented source of dose errors. The vial concentration is the single most important number for any converter.

Direct answer

A "unit" on an insulin syringe is a volume measurement, not a mass measurement. One hundred units equals 1 milliliter. Tirzepatide doses, by contrast, are expressed in milligrams (mass). The conversion between units and milligrams depends on the concentration of the specific tirzepatide vial. The formula is: volume in mL = dose in mg divided by concentration in mg/mL, then volume in mL multiplied by 100 gives units on a U-100 insulin syringe.

Table of contents

1. Units vs milligrams: a vocabulary problem
2. The U-100 insulin syringe and what its markings mean
3. The conversion formula in three lines
4. Common compounded tirzepatide concentrations
5. A unit-to-mg conversion table by concentration
6. Why FDA-approved Mounjaro and Zepbound don't use this math
7. Where dose errors come from
8. How the FormBlends calculator works
9. The contrary view on patient-driven dose math
10. Decision framework
11. FAQ
12. Sources

Units vs milligrams: a vocabulary problem

The word "units" has different meanings in different drug contexts. For insulin, one unit refers to a specific biological activity standardized by international convention. For most other injectable medications including tirzepatide, "units" refer to the markings on an insulin syringe used to measure volume.

A U-100 insulin syringe is calibrated such that 100 units of insulin (the volume containing 100 international units of biological insulin) equals 1 mL. When that same syringe is used to draw a different medication, the markings still measure volume, but the underlying drug is no longer insulin. The "unit" labels on the syringe become a convenience scale, not a biological unit.

This is the root of the confusion. A patient sees "10 units" on a syringe and assumes it means "10 milligrams of tirzepatide." It does not. It means 0.10 mL of liquid, and the milligrams in that volume depend entirely on the concentration of the medication in the vial.

The U-100 insulin syringe and what its markings mean

U-100 syringes are the standard insulin syringe in the U.S. They are sold in three common sizes: 0.3 mL (30 units), 0.5 mL (50 units), and 1 mL (100 units). The markings are typically in 1-unit or 0.5-unit increments.

Key facts about the syringe:

• 100 units = 1 mL = 1 cc
• 50 units = 0.5 mL
• 25 units = 0.25 mL
• 10 units = 0.10 mL
• 5 units = 0.05 mL

The syringe does not know what drug it is drawing. The markings show volume. The math from volume to milligrams requires the concentration.

The conversion formula in three lines

Three steps convert a prescribed milligram dose into a syringe reading.

1. Volume in mL = dose in mg / concentration in mg/mL
2. Units on a U-100 syringe = volume in mL x 100
3. Cross-check the result against the prescriber's written instructions.

Example: a patient is prescribed 2.5 mg of tirzepatide. The vial label states the concentration is 10 mg/mL.

• Volume in mL = 2.5 mg / 10 mg/mL = 0.25 mL
• Units = 0.25 mL x 100 = 25 units

The patient draws to the 25-unit mark on a U-100 syringe.

Common compounded tirzepatide concentrations

The "compounded tirzepatide" market in the U.S. is fragmented. Different 503A pharmacies prepare different concentrations based on prescriber direction and pharmacy preference. Common concentrations include:

Concentration	Volume per 1 mg	Units per 1 mg (U-100 syringe)
10 mg/mL	0.10 mL	10 units
20 mg/mL	0.05 mL	5 units
30 mg/mL	~0.033 mL	~3.3 units
40 mg/mL	0.025 mL	2.5 units

Higher concentrations mean smaller volumes per dose. This matters for patients who find small-volume injections (less than 0.10 mL) hard to measure accurately on a U-100 syringe.

A unit-to-mg conversion table by concentration

This is the kind of reference table a patient might want printed next to their refrigerator. The math is shown for the most common starting and titration doses.

Tirzepatide dose	10 mg/mL vial	20 mg/mL vial	40 mg/mL vial
2.5 mg (starting)	25 units (0.25 mL)	12.5 units (0.125 mL)	6.25 units (0.0625 mL)
5 mg	50 units (0.50 mL)	25 units (0.25 mL)	12.5 units (0.125 mL)
7.5 mg	75 units (0.75 mL)	37.5 units (0.375 mL)	18.75 units (~0.19 mL)
10 mg	100 units (1.0 mL)	50 units (0.50 mL)	25 units (0.25 mL)
12.5 mg	125 units (1.25 mL)	62.5 units (0.625 mL)	31.25 units (~0.31 mL)
15 mg (max FDA dose)	150 units (1.50 mL)	75 units (0.75 mL)	37.5 units (0.375 mL)

Two observations from this table. First, the 10 mg/mL vial requires the largest injection volumes at the higher doses (up to 1.5 mL for 15 mg), which exceeds the volume of a 1 mL syringe. Higher concentrations let patients use smaller syringes. Second, at the smallest doses on a 40 mg/mL vial, the volumes drop below the accurate measurement range of a standard insulin syringe (typically 1 unit minimum). This is one reason most pharmacies do not use 40 mg/mL for starting doses.

Why FDA-approved Mounjaro and Zepbound don't use this math

Eli Lilly's Mounjaro and Zepbound pens are FDA-approved single-use auto-injector devices. Each pen contains one fixed dose. The patient does not draw, measure, or dial. The pen delivers its labeled dose when pressed against the skin, and the unit-to-mg conversion is invisible to the user.

Mounjaro and Zepbound come in six dose strengths: 2.5, 5, 7.5, 10, 12.5, and 15 mg. Patients receive a different pen for each dose during titration. There is no syringe, no concentration math, no insulin syringe units to count.

The unit-to-mg conversation applies almost exclusively to compounded tirzepatide, which is dispensed as vials with syringes that the patient fills themselves.

Where dose errors come from

The FDA has documented dose errors in compounded tirzepatide use through its adverse event reporting system. The most common patterns:

Error 1: confusing units with milligrams. A patient hears "ten" and draws ten units instead of the correct volume. At 10 mg/mL, 10 units delivers 1 mg, not 10 mg. The dose is one tenth of intended.

Error 2: assuming the wrong concentration. A patient who switches between pharmacies may not realize the new vial has a different concentration. Using the old volume with the new concentration produces an over- or under-dose.

Error 3: misreading the syringe. The U-100 syringe markings are small. A patient who reads 25 as 2.5 (or vice versa) creates a 10-fold dose difference.

Error 4: drawing air. Failing to expel air from the syringe before the volume check leaves a smaller volume of medication than intended.

FDA's May 2023 statement on compounded GLP-1 medications cited "incorrect dose" as one of the most common safety concerns reported by patients and clinicians.

How the FormBlends calculator works

A unit-to-mg calculator is a quick double-check, not a substitute for the prescriber's instructions. The calculator takes three inputs:

1. Prescribed dose in milligrams (e.g., 2.5 mg).
2. Vial concentration from the pharmacy label (e.g., 10 mg/mL).
3. Syringe size (typically 1 mL U-100).

It outputs two values:

1. Volume in mL.
2. Units on the U-100 syringe.

The output should match the prescriber's written instruction. If it does not, the patient should stop and call the pharmacy or prescriber before injecting. A calculator that disagrees with the script is a signal something is off, not a license to follow the calculator instead.

The contrary view on patient-driven dose math

Some clinicians argue that compounded tirzepatide should not be marketed at all because it requires patients to do dose math that FDA-approved pens make unnecessary. Their case rests on several points.

Point 1: dose errors are rare with single-use auto-injectors. The pen handles the math.

Point 2: even careful patients make mistakes. Even a 5% error rate over thousands of compounded tirzepatide users translates to hundreds of incorrect doses per month.

Point 3: the cost advantage of compounded tirzepatide partly comes from shifting work to the patient (drawing, measuring, calculating) that the brand pens handle internally.

Counter-arguments: FDA-approved pens cost roughly $1,000 per month at list price as of 2026, while compounded tirzepatide may be 60-80% less expensive depending on pharmacy. For patients without insurance coverage, the cost difference is decisive. With clear pharmacy labeling and patient education, the dose-error risk can be substantially reduced.

Decision framework

If you are using FDA-approved Mounjaro or Zepbound:

• The unit-to-mg math does not apply. Use the pen as instructed.
• If you switch to compounded tirzepatide for cost or access reasons, learn the math before your first injection.

If you are using compounded tirzepatide:

• Read your vial concentration off the pharmacy label. Do not assume from past experience.
• Convert your prescribed milligram dose to units using the concentration on this vial.
• Cross-check against the written instructions from your prescriber.

If you are switching pharmacies or refilling:

• Verify the concentration of the new vial matches the old one. If not, recalculate.
• The number of units that was correct last month may be wrong this month if the concentration changed.

What this means for your dose schedule

Follow your prescriber's instructions, and do not adjust dose without their approval.

FAQ

Why don't tirzepatide units equal milligrams directly? Units measure volume on an insulin syringe; milligrams measure mass of drug. The bridge between them is concentration (mg/mL), which varies by pharmacy.

What's the most common compounded tirzepatide concentration? 10 mg/mL, 20 mg/mL, 30 mg/mL, and 40 mg/mL are typical. The pharmacy label states the concentration on each vial.

How do you calculate units from milligrams? Volume in mL equals dose in mg divided by concentration in mg/mL. Multiply mL by 100 to get units on a U-100 syringe.

Is this the same as the Mounjaro pen? No. Mounjaro uses a single-use auto-injector with a fixed dose per pen.

Why is unit conversion error common? Patients sometimes confuse units with milligrams, leading to 10-fold or larger dose errors.

What does the FormBlends tirzepatide unit calculator actually do? Converts prescribed milligrams plus vial concentration into volume (mL) and units on a U-100 syringe. It is a cross-check, not a prescription.

Is compounded tirzepatide FDA-approved? No. It is prepared by state-licensed 503A pharmacies and is not interchangeable with branded Mounjaro or Zepbound.

What if the calculator disagrees with my prescription? Stop and contact the pharmacy or prescriber. The disagreement suggests a labeling or dose error somewhere.

Can I use a 0.5 mL syringe instead of 1 mL? Yes if your dose volume is below 50 units. A 0.5 mL syringe has finer markings, which can help accuracy at smaller volumes.

Does the calculator work for semaglutide? The math is the same (volume = mg / concentration). Semaglutide compounded concentrations differ from tirzepatide, so the inputs change but the formula is identical.

Do all U-100 syringes give the same reading? Yes, as long as they are calibrated to U-100. The marking convention is universal across U-100 insulin syringes.

Sources

1. Eli Lilly. Mounjaro (tirzepatide) injection prescribing information. Revised 2024.
2. Eli Lilly. Zepbound (tirzepatide) injection prescribing information. Revised 2024.
3. FDA. Compounded versions of GLP-1 medicines: safety considerations. May 2023 statement.
4. FDA. Tirzepatide drug shortages database update. 2024.
5. USP 797. Compounding Sterile Preparations. 2023.
6. Jastreboff AM et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). New England Journal of Medicine. 2022.
7. Frias JP et al. Tirzepatide vs Semaglutide in Type 2 Diabetes (SURPASS-2). New England Journal of Medicine. 2021.
8. ISMP. Medication Safety Alert: Errors with Compounded Tirzepatide. 2024.
9. BD Medical. U-100 Insulin Syringe technical specifications. 2023.
10. Garvey WT et al. AACE/ACE Comprehensive Clinical Practice Guidelines for Medical Care of Patients with Obesity. Endocrine Practice. 2016.

Footer disclaimers

Platform Disclaimer. FormBlends connects patients with licensed prescribers and U.S. pharmacies. Unit-to-milligram calculators on our platform are reference tools, not prescriptions. Follow your written prescription and pharmacy label.

Compounded Medication Notice. Compounded tirzepatide is not FDA-approved. It is prepared by state-licensed 503A pharmacies in response to individual prescriptions. Vial concentrations vary by pharmacy and must be confirmed on each refill.

Results Disclaimer. Conversion math depends on accurate inputs. Mistakes in concentration or dose will produce incorrect outputs. The calculator does not substitute for the prescriber's clinical judgment.

Trademark Notice. Mounjaro and Zepbound are registered trademarks of Eli Lilly and Company. FormBlends is not affiliated with or endorsed by Eli Lilly.